Search Orphan Drug Designations and Approvals
-
Generic Name: | 1-{2-[3-(3,4-Dichlorophenyl)ureido]-6-methyl-pyrimidin-4-yl}-amino-3(dimethylamino)propane Di methansulfonate |
---|---|
Date Designated: | 08/02/2017 |
Orphan Designation: | Treatment of glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Curtana Pharmaceuticals, Inc. 1624 Headway Circle Austin, Texas 78754 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-